Charlotte Jones-Burton
Direttore/Membro del Consiglio presso BLUEBIRD BIO, INC.
Patrimonio netto: 16 947 $ in data 30/04/2024
Posizioni attive di Charlotte Jones-Burton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Direttore/Membro del Consiglio | 07/03/2022 | - |
| Independent Dir/Board Member | 07/03/2022 | - | |
| Women of Color in Pharma | Fondatore | - | - |
| Presidente | - | - | |
2 Flo Ventures LLC
 2 Flo Ventures LLC Investment ManagersFinance 2Flo Ventures LLC (2Flo Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Chicago, Illinois. | Investitore di Private Equity | 01/06/2024 | - |
Storia della carriera di Charlotte Jones-Burton
Precedenti posizioni note di Charlotte Jones-Burton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 24/01/2022 | 02/10/2023 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Corporate Officer/Principal | - | - |
Otsuka Pharmaceuticals (U.K.) Ltd.
 Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Corporate Officer/Principal | - | - |
Formazione di Charlotte Jones-Burton
| University of Maryland School of Medicine | Doctorate Degree |
| Washington University in St. Louis | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Otsuka Pharmaceuticals (U.K.) Ltd.
Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Health Technology |
| Women of Color in Pharma | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
2 Flo Ventures LLC
2 Flo Ventures LLC Investment ManagersFinance 2Flo Ventures LLC (2Flo Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Chicago, Illinois. | Finance |
